×

Business / Stock Market

Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONTAK (E7777)

Published Oct 13 2021 at 3:38 PM GMT

Business Insider

Business Insider @businessinsider.com

Add to Collections
Report Post

Continue reading at businessinsider.com

Key
Points

Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONTAK (E7777).

Credit

Tags

Continue reading at businessinsider.com

Posted in Business, Stock Market

Stats

Published Oct 13, 2021 3:38 PM GMT